Nautilus Biotechnology Inc (NAUT)
2.63
+0.06
(+2.33%)
USD |
NASDAQ |
Nov 05, 11:42
Nautilus Biotechnology Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Incyte Corp | 0.00 |
| Merck & Co Inc | 0.8671 |
| Neogen Corp | 0.2836 |
| Pfizer Inc | 0.7831 |
| Repligen Corp | 0.2956 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 259.70M |
| Total Liabilities (Quarterly) | 36.27M |
| Shareholders Equity (Quarterly) | 223.43M |